PFIZER vaccine side effect
Last week the U.S. Food and Drug Administration’s {FDA’s}, Center for Biologics Evaluation and Research {CBER} released 55,000- page documents about data that Pfizer submitted to FDA from its clinical trials in support of Covid-19 vaccine license. This follows the decision of U.S. District Judge Mark T. Pittman from January 6th, 2022 to deny the request from FDA to suppress the data for the next 75 years which Pfizer claimed was necessary.
Photo source: waow.com
The court has considered the Parties’ arguments, filings in support, and the applicable law, so ordered that:
1. The FDA shall produce the “more than 12,000 pages” articulated in its own proposal, see ECF No. 29 at 24, on or before January 31, 2022.
2. The FDA shall produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.
3. To the extent the FDA asserts any privilege, exemption, or exclusion as to any responsive record or portion thereof, FDA shall, concurrent with each production required by this Order, produce a redacted version of the record, redacting only those portions as to which privilege, exemption, or exclusion is asserted.
4. The Parties shall submit a Joint Status Report detailing the progress of the rolling production by April 1, 2022, and every 90 days thereafter.
The documents included an Appendix of “LIST OF ADVERSE EVENTS OF SPECIAL INTEREST”. This Appendix contains 1,291 different adverse events following vaccination including: acute kidney injury, acute flaccid myelitis, anti-sperm antibody positive, brain stem embolism, brain stem thrombosis, cardiac arrest, cardiac failure, cardiac ventricular thrombosis, cardiogenic shock, central nervous system vasculitis, death neonatal, deep vein thrombosis, encephalitis brain stem, encephalitis hemorrhagic, frontal lobe epilepsy, foaming at mouth, epileptic psychosis, facial paralysis, fetal distress syndrome, gastrointestinal amyloidosis, generalized tonic-clonic seizure, Hashimoto’s encephalopathy, hepatic vascular thrombosis, herpes zoster reactivation, immune-mediated hepatitis, interstitial lung disease, jugular vein embolism, juvenile myoclonic epilepsy, liver injury, low birth weight, multisystem inflammatory syndrome in children, myocarditis, neonatal seizure, pancreatitis, pneumonia, stillbirth, tachycardia, temporal lobe epilepsy, testicular autoimmunity, thrombotic cerebral infarction, Type 1 diabetes mellitus, venous thrombosis neonatal, and vertebral artery thrombosis among 1,246 other medical conditions.
According to the Government of Canada as of March 3th, 2022 was already confirmed total distribution of Covid 19 “vaccine” from Pfizer/BioNTech in Canada 58,853,922, in British Columbia on a total of 7,507,740.
The liberal government under Justin Trudeau committed over 9 billion CAD to procure vaccines, therapeutics, and international support to the pandemic. That amount also included the purchase of freezers, refrigerators, and dry ice for storage of the “vaccines”.
Additionally, the Canadian government has secured Covid 19 “vaccines” from Pfizer and Moderna for years 2022, 2023, with options extend into 2024. Agreement with Pfizer is up to 65 million for 2022, up to 60 million for 2023, and up to another 60 million for 2024.
Meanwhile, Pfizer made in sales from its Covid 19 “vaccines” over 47 billion CAD for the last year and doubled its overall revenue to almost 104 billion CAD. The major shareholders are Vanguard Group Inc. and Blackrock Inc. which own together almost 16% of the company.
– DB
